M. TAŞKIRAN, "An involvement of COX and 5-LOX pathways in the penicillin- and pentylenetetrazole (PTZ)-induced epilepsy models," Fundamental and Clinical Pharmacology , vol.37, no.1, pp.85-93, 2023
TAŞKIRAN, M. 2023. An involvement of COX and 5-LOX pathways in the penicillin- and pentylenetetrazole (PTZ)-induced epilepsy models. Fundamental and Clinical Pharmacology , vol.37, no.1 , 85-93.
TAŞKIRAN, M., (2023). An involvement of COX and 5-LOX pathways in the penicillin- and pentylenetetrazole (PTZ)-induced epilepsy models. Fundamental and Clinical Pharmacology , vol.37, no.1, 85-93.
TAŞKIRAN, MEHMET. "An involvement of COX and 5-LOX pathways in the penicillin- and pentylenetetrazole (PTZ)-induced epilepsy models," Fundamental and Clinical Pharmacology , vol.37, no.1, 85-93, 2023
TAŞKIRAN, MEHMET. "An involvement of COX and 5-LOX pathways in the penicillin- and pentylenetetrazole (PTZ)-induced epilepsy models." Fundamental and Clinical Pharmacology , vol.37, no.1, pp.85-93, 2023
TAŞKIRAN, M. (2023) . "An involvement of COX and 5-LOX pathways in the penicillin- and pentylenetetrazole (PTZ)-induced epilepsy models." Fundamental and Clinical Pharmacology , vol.37, no.1, pp.85-93.
@article{article, author={MEHMET TAŞKIRAN}, title={An involvement of COX and 5-LOX pathways in the penicillin- and pentylenetetrazole (PTZ)-induced epilepsy models}, journal={Fundamental and Clinical Pharmacology}, year=2023, pages={85-93} }